IRONWOOD PHARMACEUTICALS, INC. Hedging Assets, Noncurrent
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Hedging Assets, Noncurrent of $11.35 million as of 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:HedgingAssetsNoncurrent · last filed 2022-02-18
- 2021-03-31: Hedging Assets, Noncurrent $11.35M.
- 2020-12-31: Hedging Assets, Noncurrent $13.06M.
- 2020-09-30: Hedging Assets, Noncurrent $8.25M.
- 2020-06-30: Hedging Assets, Noncurrent $16.13M.
| Period end | Hedging Assets, Noncurrent |
|---|---|
| 2021-03-31 | $11.35M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $13.06M 10-K · filed 2022-02-18 |
| 2020-09-30 | $8.25M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $16.13M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $15.85M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $31.37M 10-K · filed 2021-02-17 |
| 2019-09-30 | $11.36M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $60.72M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $50.59M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $41.02M 10-K · filed 2020-02-13 |
| 2018-09-30 | $142.77M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $159.53M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $113.44M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $108.19M 10-K · filed 2019-02-25 |
| 2017-09-30 | $121.84M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $171.88M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $150.51M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $132.52M 10-K · filed 2018-02-22 |
| 2016-09-30 | $137.30M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $99.48M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $77.69M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $86.47M 10-K · filed 2017-02-22 |
| 2015-09-30 | $72.49M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $90.31M 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |